Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MAX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MSTN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC46 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCGB2A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SLC33A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NHLH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SH3KBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARMC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHD9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGF13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRAMD1C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCGF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TIA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLCG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM167A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FMR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on